Literature DB >> 25306541

Maladaptive remodeling is associated with impaired survival in women but not in men after aortic valve replacement.

George Petrov1, Elke Dworatzek2, Tabea Marie Schulze3, Michael Dandel4, Georgios Kararigas2, Shokufeh Mahmoodzadeh2, Christoph Knosalla4, Roland Hetzer4, Vera Regitz-Zagrosek5.   

Abstract

OBJECTIVES: The purpose of this study was to test whether adaptive or maladaptive remodeling is associated with survival in women and men after aortic valve replacement (AVR).
BACKGROUND: Women with isolated aortic valve stenosis (AS) develop more concentric left ventricular hypertrophy (LVH) than men in similar disease states. We recently reported less up-regulation of profibrotic genes at AVR and faster LVH regression post-operatively in women than in men, suggesting that there are sex differences in the adaptation to pressure overload and its regression.
METHODS: The study cohort included 128 patients (age 70.0 ± 9.6 years, 49% women) undergoing AVR for AS. Echocardiography was obtained before and 4.0 ± 1.6 years after surgery. Factor analysis was used to classify LVH as adaptive (combining smaller left ventricular [LV] mass/diameters and greater relative wall thicknesses) or maladaptive. Myocardial tissue samples from the LV septum were obtained during AVR to analyze cardiac fibrosis and associated key molecular regulators.
RESULTS: Before AVR, LVH was classified as adaptive in 62% of women and 45% of men (p < 0.050). Four years after AVR, adaptive LVH was observed in 75% of women and 49% of men (p < 0.031). At surgery, more cardiac fibrosis was present in men compared with women (p < 0.05). Higher levels of transforming growth factor beta 1 (p < 0.01), SMAD2 phosphorylation (p < 0.001), and periostin expression (p < 0.05) were found in men than in women. Women with maladaptive LVH had worse survival than women with adaptive LVH (p < 0.050), whereas the pattern of LVH did not affect survival in men (p < 0.307).
CONCLUSIONS: Women more frequently exhibit adaptive LV remodeling with less fibrosis than men. Maladaptive LVH is associated with worse survival in women. Thus, sex should be considered as a strong modulating factor when management of patients with AS is discussed.
Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  aortic valve replacement; aortic valve stenosis; cardiac fibrosis; gender; hypertrophy regression; sex; survival

Mesh:

Substances:

Year:  2014        PMID: 25306541     DOI: 10.1016/j.jcmg.2014.06.017

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


  30 in total

Review 1.  Connecting sex differences, estrogen signaling, and microRNAs in cardiac fibrosis.

Authors:  Lejla Medzikovic; Laila Aryan; Mansoureh Eghbali
Journal:  J Mol Med (Berl)       Date:  2019-08-26       Impact factor: 4.599

Review 2.  Sex related differences in the pathogenesis of organ fibrosis.

Authors:  Alejandra Garate-Carrillo; Julisa Gonzalez; Guillermo Ceballos; Israel Ramirez-Sanchez; Francisco Villarreal
Journal:  Transl Res       Date:  2020-03-16       Impact factor: 7.012

3.  Noninvasive Detection of Early Metabolic Left Ventricular Remodeling in Systemic Hypertension.

Authors:  Yasmin S Hamirani; Bijoy K Kundu; Min Zhong; Andrew McBride; Yinlin Li; Giovanni E Davogustto; Heinrich Taegtmeyer; Jamieson M Bourque
Journal:  Cardiology       Date:  2015-11-24       Impact factor: 1.869

Review 4.  Sex Differences in Cardiovascular Aging and Heart Failure.

Authors:  Andrew Oneglia; Michael D Nelson; C Noel Bairey Merz
Journal:  Curr Heart Fail Rep       Date:  2020-09-28

Review 5.  Calcific Aortic Valve Disease: Part 2-Morphomechanical Abnormalities, Gene Reexpression, and Gender Effects on Ventricular Hypertrophy and Its Reversibility.

Authors:  Ares Pasipoularides
Journal:  J Cardiovasc Transl Res       Date:  2016-05-16       Impact factor: 4.132

Review 6.  Valvular Heart Disease in Women, Differential Remodeling, and Response to New Therapies.

Authors:  Jaya Chandrasekhar; George Dangas; Roxana Mehran
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-09-11

Review 7.  Anti-fibrotic actions of relaxin.

Authors:  C S Samuel; S G Royce; T D Hewitson; K M Denton; T E Cooney; R G Bennett
Journal:  Br J Pharmacol       Date:  2016-07-07       Impact factor: 8.739

8.  Sex-specific regulation of collagen I and III expression by 17β-Estradiol in cardiac fibroblasts: role of estrogen receptors.

Authors:  Elke Dworatzek; Shokoufeh Mahmoodzadeh; Cindy Schriever; Kana Kusumoto; Lisa Kramer; Gabriela Santos; Daniela Fliegner; Yuet-Kin Leung; Shuk-Mei Ho; Wolfram-Hubertus Zimmermann; Susanne Lutz; Vera Regitz-Zagrosek
Journal:  Cardiovasc Res       Date:  2019-02-01       Impact factor: 10.787

9.  Sex and regional differences in myocardial plasticity in aortic stenosis are revealed by 3D model machine learning.

Authors:  Anish N Bhuva; Thomas A Treibel; Antonio De Marvao; Carlo Biffi; Timothy J W Dawes; Georgia Doumou; Wenjia Bai; Kush Patel; Redha Boubertakh; Daniel Rueckert; Declan P O'Regan; Alun D Hughes; James C Moon; Charlotte H Manisty
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2020-04-01       Impact factor: 6.875

Review 10.  Sex differences in cardiometabolic disorders.

Authors:  Eva Gerdts; Vera Regitz-Zagrosek
Journal:  Nat Med       Date:  2019-11-07       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.